4
Changes in Ownership
Cocrystal Pharma, Inc. Filed Acc 0001493152-26-027054
Options or other derivatives
- Chief Executive Officer acquired 235,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SAPIRSTEIN JAMES Chief Executive Officer | 2026-06-03 | Grant or award · Stock Options (Right to Buy) | +235,000 | 235,000 | D | ||
Loading xslF345X06/ownership.xml…